Managing Self-funded Risk
2023 Updates on Leave and Accommodation laws
Watch as Marjory Robertson, AVP & Senior Counsel, Sun Life U.S. and Abigail O’Connell, Senior Counsel, recap the latest 2023 leave and accommodation-related compliance developments.
2023 High-cost claims and injectable drug trends analysis
For the past eleven years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims.
Introduction to Gene Therapies (3rd edition)
Learn more about recently approved Hemgenix in the treatment of Hemophilia B, the gene therapy pipeline, the approval process, and what gene therapies are, in our second edition of the Introduction to Gene Therapies paper.
2022 Sun Life Stop-Loss Research Report: High-cost claims and injectable drug trends analysis
For the past ten years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims.
Webinar: 2022 High-cost claims and injectable drug trends analysis
A presentation and panel discussion on our high-cost claims and injectable drug trends analysis with insights on top claim conditions, million-dollar claims, injectable drugs, and trends we are seeing since the COVID-19 pandemic began.